Tue, 25 Feb 2020





PDF Letter is Here

The Canadian Immunohistochemistry Quality Control (CIQC) has transformed from an academic program hosted in the Departments of Pathology at the University of British Columbia and the University of Saskatchewan into two new programs to better reflect the evolving world of biomarker testing in Canadian and international laboratories.

The Canadian Pathology Quality Assurance – Assurance Qualité Canadienne en Pathologie (CPQA-AQCP) is a federal not-for-profit corporation that will focus on routine biomarker testing. To learn more about programs, please visit us at

Canadian Biomarker Quality Assurance – Programme canadien d’assurance de la qualité des biomarqueurs (CBQA-PCAB) will focus on research, development, and quality assurance of established and emerging predictive/prognostic biomarkers and will also include proficiency testing for pathologists’ biomarker readout. To learn more about programs, please visit us at CBQA is now the parent program behind the (formerly is an online program for proficiency testing of pathologists’ and technologists’ biomarker readout. As all previous CIQC laboratories are entitled to free access to, we use this opportunity to share with you the CIQC affiliation code: p7wc7Twr.
The code will be active until the end of 2020. You will need it at the time of registration at

To add to the change there are two new addresses:

Suite 363
185-9040 Blundell Road Richmond, BC
Canada V6Y 1K3

CBQA-PCAB/Dr. Emina Torlakovic Pathology, Royal University Hospital 103 Hospital Drive
Saskatoon, SK Canada
S7N 0W8


Blake Gilks, MD, FRCPC

John Garratt, RT (Cyto)
Manager, CPQA-AQCP

Emina Torlakovic, MD, PhD
Director, CBQA-PCAB


- last updated November 2017 -